Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2015

01-06-2015 | Original Article

Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?

Authors: Phuong-Mai T. Pham, Phuong-Anh T. Pham, Son V. Pham, Phuong-Truc T. Pham, Phuong-Thu T. Pham, Phuong-Chi T. Pham

Published in: Clinical and Experimental Nephrology | Issue 3/2015

Login to get access

Abstract

Background

Osmotic demyelination syndrome (ODS) is a complication generally associated with overly rapid correction of hyponatremia. Traditionally, nephrologists have been trained to focus solely on limiting the correction rate. However, there is accumulating evidence to suggest that the prevention of ODS is beyond achieving slow correction rates.

Methods

We (1) reviewed the literature for glial intracellular protective alterations during hyperosmolar stress, a state presumed equivalent to the rapid correction of hyponatremia, and (2) analyzed all available hyponatremia-associated ODS cases from PubMed for possible contributing factors including correction rates and concurrent metabolic disturbances involving hypokalemia, hypophosphatemia, hypomagnesemia, and/or hypoglycemia.

Results

In response to acute hyperosmolar stress, glial cells undergo immediate extracellular free water shift, followed by active intracellular Na+, K+ and amino acid uptake, and eventual idiogenic osmoles synthesis. At minimum, protective mechanisms require K+, Mg2+, phosphate, amino acids, and glucose. There were 158 cases of hyponatremia-associated ODS where both correction rates and other metabolic factors were documented. Compared with the rapid correction group (>0.5 mmol/L/h), the slow correction group (≤0.5 mmol/L/h) had a greater number of cases with concurrent hypokalemia (49.4 vs. 33.3 %, p = 0.04), and a greater number of cases with any concurrent metabolic derangements (55.8 vs. 38.3 %, p = 0.03).

Conclusion

Glial cell minimizes volume changes and injury in response to hyperosmolar stress via mobilization and/or utilization of various electrolytes and metabolic factors. The prevention of ODS likely requires both minimization of correction rate and optimization of intracellular response during the correction phase when a sufficient supply of various factors is necessary.
Literature
1.
go back to reference McDowell ME, Wolf AV, Steer A. Osmotic volume of distribution: idiogenic changes in osmotic pressure associated with administration of hypertonic solutions. Am J Physiol. 1955;180:545–58.PubMed McDowell ME, Wolf AV, Steer A. Osmotic volume of distribution: idiogenic changes in osmotic pressure associated with administration of hypertonic solutions. Am J Physiol. 1955;180:545–58.PubMed
2.
go back to reference Chan PH, Wong YP, Fishman RA. Hyperosmolality induced GABA release from rat brain slices. J Neurochem. 1978;30:1363–8.PubMedCrossRef Chan PH, Wong YP, Fishman RA. Hyperosmolality induced GABA release from rat brain slices. J Neurochem. 1978;30:1363–8.PubMedCrossRef
3.
go back to reference Chan PH, Fishman RA. Elevation of rat brain amino acids, ammonia and idiogenic osmoles induced by hyperosmolality. Brain Res. 1979;161:293–301.PubMedCrossRef Chan PH, Fishman RA. Elevation of rat brain amino acids, ammonia and idiogenic osmoles induced by hyperosmolality. Brain Res. 1979;161:293–301.PubMedCrossRef
4.
go back to reference Pollock AS, Arieff AI. Abnormalities of cell volume regulation and their functional consequences. Am J Physiol. 1980;239(3):F195–205.PubMed Pollock AS, Arieff AI. Abnormalities of cell volume regulation and their functional consequences. Am J Physiol. 1980;239(3):F195–205.PubMed
5.
go back to reference Heilig CW, Stromski ME, Blumenfeld JD, Lee JP, Gullans SR. Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol (Renal Fluid Electrolyte Physiol). 1989;257:F1108–16. Heilig CW, Stromski ME, Blumenfeld JD, Lee JP, Gullans SR. Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol (Renal Fluid Electrolyte Physiol). 1989;257:F1108–16.
7.
go back to reference Ayus JC, Armstrong DL, Arieff AI. Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits. J Physiol. 1996;492(Pt 1):243–55.PubMedCentralPubMedCrossRef Ayus JC, Armstrong DL, Arieff AI. Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits. J Physiol. 1996;492(Pt 1):243–55.PubMedCentralPubMedCrossRef
8.
go back to reference Adler S, Simplaceanu V. Effect of acute hyponatremia on rate brain pH and rat brain buffering. Am J Physiol. 1989;256:F113–9.PubMed Adler S, Simplaceanu V. Effect of acute hyponatremia on rate brain pH and rat brain buffering. Am J Physiol. 1989;256:F113–9.PubMed
9.
go back to reference De Petris L, Luchetti A, Emma F. Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states. Eur J Pediatr. 2001;160:71–7.PubMedCrossRef De Petris L, Luchetti A, Emma F. Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states. Eur J Pediatr. 2001;160:71–7.PubMedCrossRef
10.
go back to reference Bito LZ, Myers RE. On the physiological response of the cerebral cortex to acute stress (reversible asphyxia). J Physiol (Lond). 1972;221:349–70.CrossRef Bito LZ, Myers RE. On the physiological response of the cerebral cortex to acute stress (reversible asphyxia). J Physiol (Lond). 1972;221:349–70.CrossRef
11.
go back to reference Franchi-Gazzola R, Dall’Asta V, Sala R, et al. The role of the neutral amino acid transporter SNAT2 in cell volume regulation. Acta Physiol (Oxf). 2006;187:273–83.CrossRef Franchi-Gazzola R, Dall’Asta V, Sala R, et al. The role of the neutral amino acid transporter SNAT2 in cell volume regulation. Acta Physiol (Oxf). 2006;187:273–83.CrossRef
12.
go back to reference Thurston JH, Hauhart RE, Dirgo JA, Schulz DW. Effects of acute hyperosmolar NaCl or urea on brain H2O, Na+, K+, carbohydrate, and amino acid metabolism in weanling mice: NaCl induces insulin secretion and hypoglycemia. Metab Brain Dis. 1986;1(2):129–46.PubMedCrossRef Thurston JH, Hauhart RE, Dirgo JA, Schulz DW. Effects of acute hyperosmolar NaCl or urea on brain H2O, Na+, K+, carbohydrate, and amino acid metabolism in weanling mice: NaCl induces insulin secretion and hypoglycemia. Metab Brain Dis. 1986;1(2):129–46.PubMedCrossRef
13.
go back to reference Vallurupalli S, Huesmann G, Gregory J, Jakoby MG IV. Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. Diabetic Med. 2008;25:856–9.PubMedCentralPubMedCrossRef Vallurupalli S, Huesmann G, Gregory J, Jakoby MG IV. Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. Diabetic Med. 2008;25:856–9.PubMedCentralPubMedCrossRef
14.
go back to reference Madey JJ, Hannah JA, Lazaridis C. Central pontine myelinolysis following acute hypoglycemia. Clin Neurol Neurosurg. 2013;115(10):2299–300.PubMedCrossRef Madey JJ, Hannah JA, Lazaridis C. Central pontine myelinolysis following acute hypoglycemia. Clin Neurol Neurosurg. 2013;115(10):2299–300.PubMedCrossRef
15.
go back to reference Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke. 1996;27:1648–55.PubMedCrossRef Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke. 1996;27:1648–55.PubMedCrossRef
16.
go back to reference Yan S, Rivkees SA. Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport. 2006;17:55–9.PubMedCrossRef Yan S, Rivkees SA. Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport. 2006;17:55–9.PubMedCrossRef
17.
go back to reference Suh WS, Gun ET, Hambu AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest. 2007;117:910–8.PubMedCentralPubMedCrossRef Suh WS, Gun ET, Hambu AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest. 2007;117:910–8.PubMedCentralPubMedCrossRef
18.
go back to reference Thompson PD, Gledhill RF, Quinn NP, Rossor MN, Stanley P, Coomes EN. Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wenicke’s encephalopathy. Br Med J. 1986;292(6521):684–5.CrossRef Thompson PD, Gledhill RF, Quinn NP, Rossor MN, Stanley P, Coomes EN. Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wenicke’s encephalopathy. Br Med J. 1986;292(6521):684–5.CrossRef
19.
go back to reference Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med. 1999;37:1011–33.PubMed Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med. 1999;37:1011–33.PubMed
20.
go back to reference King JD, Rosner MH. Osmotic demyelination syndrome. Am J Med Sci. 2010;339(6):561–7.PubMed King JD, Rosner MH. Osmotic demyelination syndrome. Am J Med Sci. 2010;339(6):561–7.PubMed
21.
go back to reference Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81(2):154–72.PubMedCrossRef Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81(2):154–72.PubMedCrossRef
22.
go back to reference Khan LU, Ahmed J, Khan S, Macfie J. Refeeding syndrome: a literature review. Gastroenterol Res Pract 2011; Article ID 410971. Khan LU, Ahmed J, Khan S, Macfie J. Refeeding syndrome: a literature review. Gastroenterol Res Pract 2011; Article ID 410971.
23.
go back to reference Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med. 1994;96(5):408–13.PubMedCrossRef Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med. 1994;96(5):408–13.PubMedCrossRef
24.
go back to reference Ruiz S, Alzieu M, Niquet L, Vergne S, Lathuile D, Campistron J. Severe hyponatraemia and central pontine myelinolysis: be careful with other factors! Ann Fr Anesth Reanim. 2009;28(1):96–9.PubMedCrossRef Ruiz S, Alzieu M, Niquet L, Vergne S, Lathuile D, Campistron J. Severe hyponatraemia and central pontine myelinolysis: be careful with other factors! Ann Fr Anesth Reanim. 2009;28(1):96–9.PubMedCrossRef
25.
go back to reference Turnbull J, Lumsden D, Siddigui A, Lin JP, Lim M. Osmotic demyelination syndrome associated with hypophosphataemia: 2 cases and a review of literature. Acta Paediatr. 2013;102:164–8.CrossRef Turnbull J, Lumsden D, Siddigui A, Lin JP, Lim M. Osmotic demyelination syndrome associated with hypophosphataemia: 2 cases and a review of literature. Acta Paediatr. 2013;102:164–8.CrossRef
26.
27.
go back to reference Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol. 2011;55(3):248–53. Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol. 2011;55(3):248–53.
28.
go back to reference Ramaekers VT, Reul J, Kusenbach G, Thron A, Heimann Gn. Central pontine myelinolysis associated with acquired folate depletion. Neuropediatrics. 1997;28(2):126–30.PubMedCrossRef Ramaekers VT, Reul J, Kusenbach G, Thron A, Heimann Gn. Central pontine myelinolysis associated with acquired folate depletion. Neuropediatrics. 1997;28(2):126–30.PubMedCrossRef
29.
go back to reference Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y. Rapid development of central pontine myelinolysis after recovery from wernicke encephalopathy: a non-alcoholic case without hyponatremia. Intern Med. 2012;51(12):1599–603 Epub 2012 Jun 15.PubMedCrossRef Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y. Rapid development of central pontine myelinolysis after recovery from wernicke encephalopathy: a non-alcoholic case without hyponatremia. Intern Med. 2012;51(12):1599–603 Epub 2012 Jun 15.PubMedCrossRef
30.
go back to reference An JY, Park SK, Han SR, Song IU. Central pontine and extrapontine myelinolysis that developed during alcohol withdrawal, without hyponatremia, in a chronic alcoholic. Intern Med. 2010;49(6):615–8 Epub 2010 Mar 15.PubMedCrossRef An JY, Park SK, Han SR, Song IU. Central pontine and extrapontine myelinolysis that developed during alcohol withdrawal, without hyponatremia, in a chronic alcoholic. Intern Med. 2010;49(6):615–8 Epub 2010 Mar 15.PubMedCrossRef
31.
32.
go back to reference Ashrafian A, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol. 2001;8(2):103–9.PubMedCrossRef Ashrafian A, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol. 2001;8(2):103–9.PubMedCrossRef
33.
go back to reference Rose BD (ed): Clinical physiology of acid-base and electrolyte disorders (ed 4). New York, NY: McGraw-Hill; 1994. p. 679. Rose BD (ed): Clinical physiology of acid-base and electrolyte disorders (ed 4). New York, NY: McGraw-Hill; 1994. p. 679.
34.
go back to reference Edelman IS, Leibman J, O’meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37(9):1236–56.PubMedCentralPubMedCrossRef Edelman IS, Leibman J, O’meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37(9):1236–56.PubMedCentralPubMedCrossRef
36.
go back to reference Pham PC, Chen PV, Pham PT. Over-correction of hyponatremia: where do we go wrong? Am J Kidney Dis. 2000;36(2):E12.PubMedCrossRef Pham PC, Chen PV, Pham PT. Over-correction of hyponatremia: where do we go wrong? Am J Kidney Dis. 2000;36(2):E12.PubMedCrossRef
37.
go back to reference Madhusooman S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatremia associated with psychotropic medications: a review of the literature and spontaneous reports. Advers Drug React Toxicol Rev. 2002;21:17–29.CrossRef Madhusooman S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatremia associated with psychotropic medications: a review of the literature and spontaneous reports. Advers Drug React Toxicol Rev. 2002;21:17–29.CrossRef
38.
go back to reference Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence of risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211–7.PubMedCentralPubMedCrossRef Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence of risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211–7.PubMedCentralPubMedCrossRef
39.
go back to reference Almond CSD, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Bostom Marathon. N Engl J Med. 2005;352:1550–6.PubMedCrossRef Almond CSD, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Bostom Marathon. N Engl J Med. 2005;352:1550–6.PubMedCrossRef
Metadata
Title
Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?
Authors
Phuong-Mai T. Pham
Phuong-Anh T. Pham
Son V. Pham
Phuong-Truc T. Pham
Phuong-Thu T. Pham
Phuong-Chi T. Pham
Publication date
01-06-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1021-y

Other articles of this Issue 3/2015

Clinical and Experimental Nephrology 3/2015 Go to the issue